期刊文献+

养肝益水颗粒对SHR大鼠血压及ET-1、NO的影响 被引量:8

Effect of yangganyishui granule on blood pressure,ET-1 and NO in SHR
下载PDF
导出
摘要 目的通过对自发性高血压大鼠(SHR)血压、循环及肾脏组织内皮素(ET-1)、一氧化氮(NO)浓度的检测,观察养肝益水颗粒对SHR大鼠肾脏保护作用。方法将SHR大鼠随机分为养肝益水颗粒治疗组(以下简称养肝益水组)、卡托普利治疗组(以下简称卡托普利组)、模型对照组,每组均8只,Wistar-Kyoto(WKY)大鼠8只作为正常对照组。灌胃6周后处死,检测其血压、循环及肾脏组织内ET-1及NO的浓度。结果养肝益水颗粒能降低SHR大鼠血压进行性增高的趋势;治疗后养肝益水组循环ET-1浓度略有下降,但与模型对照组比较无明显差异(P>0.05);治疗后养肝益水组肾脏组织ET-1浓度较模型对照组有显著下降,其差异有统计学意义(P<0.01);治疗后养肝益水组循环NO浓度略有升高,但与模型对照组比较无明显差异(P>0.05),与正常对照组比较其差异有统计学意义(P<0.05);治疗后养肝益水组肾脏组织NO浓度较模型对照组有显著升高,其差异有统计学意义(P<0.01)。结论养肝益水颗粒能持久降低SHR大鼠血压,降低SHR大鼠肾脏组织ET-1浓度;升高SHR大鼠肾脏组织NO浓度,从而起到保护肾脏的作用。 Aim To observe the protective effect of yangganyishui granule on spontaneous hypertension rats (SHR) with early renal damage by detecting the blood pressure, endothelin-1 ( ET-1 ) concentrations and nitricoxide (NO) concentrations of SHR. Methods Twenty-four SHR were randomly divided into three groups which include yangganyishui granule group, captopril group, model control group. Each group has eight rats. Besides, eight Wistar-Kyoto(WKY) rats belong to normal control group. After 6 weeks, all of the rats were put to death. Their blood pressure,ET-1 concentrations and NO concentrations were measured. Results yangganyishui granule group could reduce their increasing blood pressure. The comparison of the circulating ET-1 concentrations between yangganyishui granule group and model control group was not statistically significant ( P 〉 0.05 ) after treatment. The nephric ET-1 concentrations of the yangganyishui granule group has some statistical significance (P 〈0.01 ) compared with the model control group after treatment. There was no statisticall significance ( P 〉 0.05 ) in circulating NO concentrations of the yangganyishui granule group were compared with the model control group after treatment. BUt, there is statistical significance ( P 〈 0.05 ) compared with the normal control group. It was statistically significant (P 〈 0.01 ) when the nephric NO concentrations of the yangganyishui granule group was compared with the model control group after treatment. Conclusions Firstly, yangganyishui granule could persistently decrease the SHR' s blood pressure. Secondly,it could not only decrease the nephric ET-1 concentrations but increase the nephric NO concentrations. Therefore,it has some protective effects on spontaneous hypertension rats(SHR) with early renal damage.
出处 《安徽医药》 CAS 2009年第2期147-149,共3页 Anhui Medical and Pharmaceutical Journal
关键词 养肝益水颗粒 自发性高血压大鼠 早期.肾损害 血压 ET-1 NO yangganyishui granule spontaneous hypertension rats early renal damage blood pressure endothelin ( ET- 1 ) nitricoxide (NO)
  • 相关文献

参考文献6

二级参考文献25

  • 1顾健霞.周氏养肝益水颗粒减轻原发性高血压早期肾损害的作用观察[J].中医药临床杂志,2005,17(4):373-374. 被引量:15
  • 2汪其存,余晓燕,许克莲.高血压患者278例临床分析[J].安徽医药,2006,10(8):597-598. 被引量:6
  • 3[1]Lijnen HR, Colle D. Impaired fibrinolysin and the risk for coronary heart disease[J]. Circulation, 1996,94:2025-2032.
  • 4[2]Kim A, Geoffery H, Martin G, et al. Association of blood pressure with fibrinolytic potential in the Framingham offspring population [J]. Circulation, 2001,101 (3): 264-270.
  • 5[3]Ernesto L, Jeong B P, Hope D, et al. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist lorsartan[J]. Circulation,2000,101 (14): 1653-1657.
  • 6[4]Nancy J, Brown MD, James V, et al. Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through β2 recepto-dependent, No synthase-independent and cyclooxygennase-independent pathway[J]. Circulation, 2000, 102:2190-2196.
  • 7[5]Kohno M. Plasma immunoreactive endothelin-1 in experimental malignant hypertension[J]. Hypertension, 1991,18:93-100.
  • 8[6]Mimran A, Ruilope L, Kerwin L, et al. Comparison of the angiotensin Ⅱ receptor antagonist, irbesartan, with the full dose range of enalapril for the treatment of hypertension (abst) [J]. J Hypertens, 1997,15(suppl4): s117-s123.
  • 9[7]Kochar M, Zabiocki C J, Guthrie R, et al. Irbesartan in combination with hydrochlorothiazide in mild-to-moderate hypertension (abst) [J]. Am J Hypertens, 1997,10(4,part2): 106A-107A.
  • 10傅仁杰.老年高血压病的辨证论治[J].中医杂志,1993,(8):495-495.

共引文献125

同被引文献137

引证文献8

二级引证文献114

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部